cGMP-dependent protein kinases (cGK)

Methods in Molecular Biology

Volumn 1020, Issue , 2013, Pages 17-50

  Hofmann, Franz ^a   Wegener, Jörg W ^a  

^a TECHNICAL UNIVERSITY OF MUNICH   (Germany)

Author keywords

Cardiovascular; Cell growth; cGKs; Metabolism; Non cardiovascular

Indexed keywords

ALDOSTERONE; ATRIAL NATRIURETIC FACTOR; BRAIN NATRIURETIC PEPTIDE; CALCINEURIN; CALCIUM CHANNEL; CYCLIC GMP DEPENDENT PROTEIN KINASE; GELATINASE A; GELATINASE B; GLYCOGEN SYNTHASE KINASE 3; HEAT SHOCK PROTEIN 20; MITOGEN ACTIVATED PROTEIN KINASE 1; NATRIURETIC PEPTIDE TYPE C; NITRIC OXIDE; PHOSPHOLIPASE C; PHOSPHOPROTEIN PHOSPHATASE 1; POTASSIUM CHANNEL; RGS2 PROTEIN; TISSUE INHIBITOR OF METALLOPROTEINASE 2; TRANSCRIPTION FACTOR NFAT; TRANSIENT RECEPTOR POTENTIAL CHANNEL 6;

ADIPOCYTE; ADRENAL GLAND; ALDOSTERONE RELEASE; APOPTOSIS; ARTICLE; ATHEROSCLEROSIS; BLOOD PRESSURE; BLOOD PRESSURE REGULATION; BONE GROWTH; CALCIUM CURRENT; CELL ADHESION; CELL DEDIFFERENTIATION; CELLULAR DISTRIBUTION; CIRCADIAN RHYTHM; ENCHONDRAL OSSIFICATION; ENZYME DEGRADATION; ENZYME LOCALIZATION; ENZYME PHOSPHORYLATION; GENE DELETION; GLUCOSE HOMEOSTASIS; HEART FAILURE; HEART FAILURE WITH PRESERVED EJECTION FRACTION; HEART MUSCLE CONTRACTILITY; HEART MUSCLE TENSION; HEART VENTRICLE HYPERTROPHY; HUMAN; HYPERGLYCEMIA; HYPERPOLARIZATION; INOTROPISM; KIDNEY; MEMBRANE DEPOLARIZATION; METABOLISM; MUSCLE RELAXATION; NEGATIVE FEEDBACK; NONHUMAN; PRIORITY JOURNAL; RECEPTOR POTENTIAL; RENIN RELEASE; RESTENOSIS; SIGNAL TRANSDUCTION; SMOOTH MUSCLE RELAXATION; SMOOTH MUSCLE TONE; TISSUE DISTRIBUTION; VASCULAR SMOOTH MUSCLE; VASODILATATION;

EUKARYOTA; MAMMALIA;

EID: 84883188866     PISSN: 10643745     EISSN: None     Source Type: Book Series    
DOI: 10.1007/978-1-62703-459-3_2     Document Type: Article

References (301)

1. Friebe A, Koesling D (2003) Regulation of nitric oxide-sensitive guanylyl cyclase. Circ Res 93(2):96-105
2. Katsuki S, Arnold W, Mittal C, Murad F (1977) Stimulation of guanylate cyclase by sodium nitroprusside, nitroglycerin and nitric oxide in various tissue preparations and comparison to the effects of sodium azide and hydroxylamine. J Cyclic Nucleotide Res 3(1):23-35
3. Garbers DL (1992) Guanylyl cyclase receptors and their endocrine, paracrine, and autocrine ligands. Cell 71(1):1-4
4. Rybalkin SD, Yan C, Bornfeldt KE, Beavo JA (2003) Cyclic GMP phosphodiesterases and regulation of smooth muscle function. Circ Res 93(4):280-291
5. Bender AT, Beavo JA (2006) Cyclic nucleotide phosphodiesterases: Molecular regulation to clinical use. Pharmacol Rev 58(3):488-520
6. Biel M, Zong X, Ludwig A, Sautter A, Hofmann F (1999) Structure and function of cyclic nucleotide-gated channels. Rev Physiol Biochem Pharmacol 135:151-171
7. Hofmann F, Biel M, Feil R, Kleppisch T (2004) Mouse models of NO/natriuretic peptide/cGMP kinase signaling. In: Offermanns S (ed) Handbook of experimental pharmacology, vol 159, Transgenic models in pharmacology. Elsevier, Amsterdam, pp 95-130
8. Hofmann F (2005) The biology of cyclic GMP-dependent protein kinases. J Biol Chem 280(1):1-4
9. Pfeifer A, Ruth P, Dostmann W, Sausbier M, Klatt P, Hofmann F (1999) Structure and function of cGMP-dependent protein kinases. Rev Physiol Biochem Pharmacol 135:105-149
10. Feil R, Lohmann SM, de Jonge H, Walter U, Hofmann F (2003) Cyclic GMP-dependent protein kinases and the cardiovascular system: Insights from genetically modified mice. Circ Res 93(10):907-916
11. Hess DT, Matsumoto A, Kim SO, Marshall HE, Stamler JS (2005) Protein S-nitrosylation: Purview and parameters. Nat Rev Mol Cell Biol 6(2):150-166
12. Burkhardt M, Glazova M, Gambaryan S, Vollkommer T, Butt E, Bader B, Heermeier K, Lincoln TM, Walter U, Palmetshofer A (2000) KT5823 inhibits cGMP-dependent protein kinase activity in vitro but not in intact human platelets and rat mesangial cells. J Biol Chem 275(43):33536-33541
13. Marshall SJ, Senis YA, Auger JM, Feil R, Hofmann F, Salmon G, Peterson JT, Burslem F, Watson SP (2004) GPIb-dependent platelet activation is dependent on Src kinases but not MAP kinase or cGMP-dependent kinase. Blood 103(7):2601-2609
14. Wyatt TA, Pryzwansky KB, Lincoln TM (1991) KT5823 activates human neutrophils and fails to inhibit cGMP-dependent protein kinase phosphorylation of vimentin. Res Commun Chem Pathol Pharmacol 74(1):3-14
15. Daugirdas JT, Zhou HL, Tamulaitis VV, Nutting CW, Fiscus RR (1991) Effect of H-8, an isoquinolinesulfonamide inhibitor of cyclic nucleotide-dependent protein kinase, on cAMP- and cGMP-mediated vasorelaxation. Blood Vessels 28(5):366-371
16. Valtcheva N, Nestorov P, Beck A, Russwurm M, Hillenbrand M, Weinmeister P, Feil R (2009) The commonly used cGMP-dependent protein kinase type I (cGKI) inhibitor Rp-8-Br-PET-cGMPS can activate cGKI in vitro and in intact cells. J Biol Chem 284(1):556-562. doi: 10.1074/jbc. M806161200
17. Hofmann F, Bernhard D, Lukowski R, Weinmeister P (2009) cGMP regulated protein kinases (cGK). Handb Exp Pharmacol 191:137-162
18. Francis SH, Busch JL, Corbin JD, Sibley D (2010) cGMP-dependent protein kinases and cGMP phosphodiesterases in nitric oxide and cGMP action. Pharmacol Rev 62(3):525-563
19. D'Souza SP, Davis M, Baxter GF (2004) Autocrine and paracrine actions of natriuretic peptides in the heart. Pharmacol Ther 101(2):113-129
20. Garbers DL, Dubois SK (1999) The molecular basis of hypertension. Annu Rev Biochem 68:127-155
21. Lloyd-Jones DM, Bloch KD (1996) The vascular biology of nitric oxide and its role in atherogenesis. Annu Rev Med 47:365-375
22. Massion PB, Feron O, Dessy C, Balligand JL (2003) Nitric oxide and cardiac function: Ten years after, and continuing. Circ Res 93(5):388-398
23. Ignarro LJ (2002) Nitric oxide as a unique signaling molecule in the vascular system: A historical overview. J Physiol Pharmacol 53(4 Pt 1):503-514
24. Shimokawa H, Tsutsui M (2010) Nitric oxide synthases in the pathogenesis of cardiovascular disease: Lessons from genetically modified mice. Pflugers Arch 459(6):959-967. doi: 10.1007/s00424-010-0796-2
25. Ziolo MT, Kohr MJ, Wang H (2008) Nitric oxide signaling and the regulation of myocardial function. J Mol Cell Cardiol 45(5):625-632. doi: 10.1016/j.yjmcc.2008.07.015
26. Abassi Z, Karram T, Ellaham S, Winaver J, Hoffman A (2004) Implications of the natriuretic peptide system in the pathogenesis of heart failure: Diagnostic and therapeutic importance. Pharmacol Ther 102(3):223-241. doi: 10.1016/j.pharmthera.2004.04.004
27. Roy LF, Ogilvie RI, Larochelle P, Hamet P, Leenen FH (1989) Cardiac and vascular effects of atrial natriuretic factor and sodium nitroprusside in healthy men. Circulation 79(2):383-392
28. Moncada S, Higgs A (1993) The l -argininenitric oxide pathway. N Engl J Med 329(27):2002-2012. doi: 10.1056/NEJM199312303292706
29. Matsumoto T, Wada A, Tsutamoto T, Omura T, Yokohama H, Ohnishi M, Nakae I, Takahashi M, Kinoshita M (1999) Vasorelaxing effects of atrial and brain natriuretic peptides on coronary circulation in heart failure. Am J Physiol 276(6 Pt 2):H1935-H1942
30. Winquist RJ, Faison EP, Waldman SA, Schwartz K, Murad F, Rapoport RM (1984) Atrial natriuretic factor elicits an endotheliumindependent relaxation and activates particulate guanylate cyclase in vascular smooth muscle. Proc Natl Acad Sci USA 81(23):7661-7664
31. Inagami T (1994) Atrial natriuretic factor as a volume regulator. J Clin Pharmacol 34(5):424-426
32. Ishibashi T, Hamaguchi M, Kato K, Kawada T, Ohta H, Sasage H, Imai S (1993) Relationship between myoglobin contents and increases in cyclic GMP produced by glyceryl trinitrate and nitric oxide in rabbit aorta, right atrium and papillary muscle. Naunyn Schmiedebergs Arch Pharmacol 347(5):553-561
33. Yanagisawa T, Hashimoto H, Taira N (1988) The negative inotropic effect of nicorandil is independent of cyclic GMP changes: A comparison with pinacidil and cromakalim in canine atrial muscle. Br J Pharmacol 95(2):393-398
34. Cramb G, Banks R, Rugg EL, Aiton JF (1987) Actions of atrial natriuretic peptide (ANP) on cyclic nucleotide concentrations and phosphatidylinositol turnover in ventricular myocytes. Biochem Biophys Res Commun 148(3):962-970
35. Mullershausen F, Friebe A, Feil R, Thompson WJ, Hofmann F, Koesling D (2003) Direct activation of PDE5 by cGMP: Long-term effects within NO/cGMP signaling. J Cell Biol 160(5):719-727
36. Kuhn M (2003) Structure, regulation, and function of mammalian membrane guanylyl cyclase receptors, with a focus on guanylyl cyclase-A. Circ Res 93(8):700-709
37. Francis SH, Busch JL, Corbin JD, Sibley D (2010) cGMP-dependent protein kinases and cGMP phosphodiesterases in nitric oxide and cGMP action. Pharmacol Rev 62(3):525-563. doi: 10.1124/pr.110.002907
38. Ecker T, Gobel C, Hullin R, Rettig R, Seitz G, Hofmann F (1989) Decreased cardiac concentration of cGMP kinase in hypertensive animals. An index for cardiac vascularization? Circ Res 65(5):1361-1369
39. Wegener JW, Nawrath H, Wolfsgruber W, Kuhbandner S, Werner C, Hofmann F, Feil R (2002) cGMP-dependent protein kinase I mediates the negative inotropic effect of cGMP in the murine myocardium. Circ Res 90(1):18-20
40. Takimoto E, Champion HC, Li M, Belardi D, Ren S, Rodriguez ER, Bedja D, Gabrielson KL, Wang Y, Kass DA (2005) Chronic inhibition of cyclic GMP phosphodiesterase 5A prevents and reverses cardiac hypertrophy. Nat Med 11(2):214-222
41. MacDonell KL, Diamond J (1997) Cyclic GMP-dependent protein kinase activation in the absence of negative inotropic effects in the rat ventricle. Br J Pharmacol 122(7):1425-1435. doi: 10.1038/sj.bjp.0701492
42. Pierkes M, Gambaryan S, Boknik P, Lohmann SM, Schmitz W, Potthast R, Holtwick R, Kuhn M (2002) Increased effects of C-type natriuretic peptide on cardiac ventricular contractility and relaxation in guanylyl cyclase A-deficient mice. Cardiovasc Res 53(4):852-861
43. Lukowski R, Rybalkin SD, Loga F, Leiss V, Beavo JA, Hofmann F (2010) Cardiac hypertrophy is not amplified by deletion of cGMPdependent protein kinase I in cardiomyocytes. Proc Natl Acad Sci USA 107(12):5646-5651. doi: 10.1073/pnas.1001360107
44. Mery PF, Lohmann SM, Walter U, Fischmeister R (1991) Ca 2+ current is regulated by cyclic GMP-dependent protein kinase in mammalian cardiac myocytes. Proc Natl Acad Sci USA 88(4):1197-1201
45. George WJ, Polson JB, O'Toole AG, Goldberg ND (1970) Elevation of guanosine 3 ¢, 5 ¢ -cyclic phosphate in rat heart after perfusion with acetylcholine. Proc Natl Acad Sci USA 66(2):398-403
46. Watanabe AM, Besch HR Jr (1975) Interaction between cyclic adenosine monophosphate and cyclic gunaosine monophosphate in guinea pig ventricular myocardium. Circ Res 37(3):309-317
47. MacDonell KL, Tibbits GF, Diamond J (1995) cGMP elevation does not mediate muscarinic agonist-induced negative inotropy in rat ventricular cardiomyocytes. Am J Physiol 269(6 Pt 2):H1905-H1912
48. Hayek S, Nemer M (2011) Cardiac natriuretic peptides: From basic discovery to clinical practice. Cardiovasc Ther 29(6):362-376. doi: 10.1111/j.1755-5922.2010.00152.x\\
49. Wegener JW, Gath I, Forstermann U, Nawrath H (1997) Activation of soluble guanylyl cyclase by YC-1 in aortic smooth muscle but not in ventricular myocardium from rat. Br J Pharmacol 122(7):1523-1529. doi: 10.1038/sj.bjp. 0701542
50. Rosenkranz AC, Woods RL, Dusting GJ, Ritchie RH (2003) Antihypertrophic actions of the natriuretic peptides in adult rat cardiomyocytes: Importance of cyclic GMP. Cardiovasc Res 57(2):515-522
51. Hiwatari M, Satoh K, Angus JA, Johnston CI (1986) No effect of atrial natriuretic factor on cardiac rate, force and transmitter release. Clin Exp Pharmacol Physiol 13(2):163-168
52. Bergey JL, Kotler D (1985) Effects of atriopeptins I, II and III on atrial contractility, sinus nodal rate (guinea pig) and agonistinduced tension in rabbit aortic strips. Eur J Pharmacol 110(2):277-281
53. Bohm M, Diet F, Pieske B, Erdmann E (1988) h-ANF does not play a role in the regulation of myocardial force of contraction. Life Sci 43(16):1261-1267
54. Neyses L, Vetter H (1989) Action of atrial natriuretic peptide and angiotensin II on the myocardium: Studies in isolated rat ventricular cardiomyocytes. Biochem Biophys Res Commun 163(3):1435-1443
55. Brusq JM, Mayoux E, Guigui L, Kirilovsky J (1999) Effects of C-type natriuretic peptide on rat cardiac contractility. Br J Pharmacol 128(1):206-212. doi: 10.1038/sj.bjp.0702766
56. Wollert KC, Yurukova S, Kilic A, Begrow F, Fiedler B, Gambaryan S, Walter U, Lohmann SM, Kuhn M (2003) Increased effects of C-type natriuretic peptide on contractility and calcium regulation in murine hearts overexpressing cyclic GMP-dependent protein kinase I. Br J Pharmacol 140(7):1227-1236
57. Castro LR, Schittl J, Fischmeister R (2010) Feedback control through cGMP-dependent protein kinase contributes to differential regulation and compartmentation of cGMP in rat cardiac myocytes. Circ Res 107(10):1232-1240. doi: 10.1161/CIRCRESAHA.110.226712
58. Piggott LA, Hassell KA, Berkova Z, Morris AP, Silberbach M, Rich TC (2006) Natriuretic peptides and nitric oxide stimulate cGMP synthesis in different cellular compartments. J Gen Physiol 128(1):3-14. doi: 10.1085/jgp.200509403
59. Hare JM, Stamler JS (2005) NO/redox disequilibrium in the failing heart and cardiovascular system. J Clin Invest 115(3):509-517
60. Ziolo MT (2008) The fork in the nitric oxide road: Cyclic GMP or nitrosylation? Nitric Oxide 18(3):153-156. doi: 10.1016/j. niox.2008.01.008
61. Hendgen-Cotta UB, Flogel U, Kelm M, Rassaf T (2010) Unmasking the Janus face of myoglobin in health and disease. J Exp Biol 213(Pt 16):2734-2740. doi: 10.1242/jeb.041178
62. Wegener JW, Godecke A, Schrader J, Nawrath H (2002) Effects of nitric oxide donors on cardiac contractility in wild-type and myoglobindeficient mice. Br J Pharmacol 136(3):415-420. doi: 10.1038/sj.bjp.0704740
63. Maulik N, Engelman DT, Watanabe M, Engelman RM, Maulik G, Cordis GA, Das DK (1995) Nitric oxide signaling in ischemic heart. Cardiovasc Res 30(4):593-601
64. Kojda G, Kottenberg K, Nix P, Schluter KD, Piper HM, Noack E (1996) Low increase in cGMP induced by organic nitrates and nitrovasodilators improves contractile response of rat ventricular myocytes. Circ Res 78(1):91-101
65. Kohr MJ, Wang H, Wheeler DG, Velayutham M, Zweier JL, Ziolo MT (2008) Biphasic effect of SIN-1 is reliant upon cardiomyocyte contractile state. Free Radic Biol Med 45(1):73-80. doi: 10.1016/j. freeradbiomed.2008.03.019
66. Han X, Kubota I, Feron O, Opel DJ, Arstall MA, Zhao YY, Huang P, Fishman MC, Michel T, Kelly RA (1998) Muscarinic cholinergic regulation of cardiac myocyte ICa-L is absent in mice with targeted disruption of endothelial nitric oxide synthase. Proc Natl Acad Sci USA 95(11):6510-6515
67. Hare JM, Colucci WS (1995) Role of nitric oxide in the regulation of myocardial function. Prog Cardiovasc Dis 38(2):155-166
68. Vandecasteele G, Eschenhagen T, Scholz H, Stein B, Verde I, Fischmeister R (1999) Muscarinic and beta-adrenergic regulation of heart rate, force of contraction and calcium current is preserved in mice lacking endothelial nitric oxide synthase. Nat Med 5(3):331-334
69. Godecke A, Heinicke T, Kamkin A, Kiseleva I, Strasser RH, Decking UK, Stumpe T, Isenberg G, Schrader J (2001) Inotropic response to beta-adrenergic receptor stimulation and anti- adrenergic effect of ACh in endothelial NO synthase-deficient mouse hearts. J Physiol 532(Pt 1):195-204
70. Yang L, Liu G, Zakharov SI, Bellinger AM, Mongillo M, Marx SO (2007) Protein kinase G phosphorylates Cav1.2 alpha1c and beta2 subunits. Circ Res 101(5):465-474
71. Rodriguez-Pascual F, Ferrero R, Miras-Portugal MT, Torres M (1999) Phosphorylation of tyrosine hydroxylase by cGMP-dependent protein kinase in intact bovine chromaffin cells. Arch Biochem Biophys 366(2):207-214. doi: 10.1006/abbi.1999.1199
72. Wang Y, Wagner MB, Joyner RW, Kumar R (2000) cGMP-dependent protein kinase mediates stimulation of l -type calcium current by cGMP in rabbit atrial cells. Cardiovasc Res 48(2):310-322
73. Wahler GM, Dollinger SJ (1995) Nitric oxide donor SIN-1 inhibits mammalian cardiac calcium current through cGMP-dependent protein kinase. Am J Physiol 268(1 Pt 1):C45-C54
74. Schroder F, Klein G, Fiedler B, Bastein M, Schnasse N, Hillmer A, Ames S, Gambaryan S, Drexler H, Walter U, Lohmann SM, Wollert KC (2003) Single l -type Ca (2+) channel regulation by cGMP-dependent protein kinase type I in adult cardiomyocytes from PKG I transgenic mice. Cardiovasc Res 60(2):268-277
75. Fischmeister R, Castro L, Abi-Gerges A, Rochais F, Vandecasteele G (2005) Speciesand tissue-dependent effects of NO and cyclic GMP on cardiac ion channels. Comp Biochem Physiol A Mol Integr Physiol 142(2):136-143. doi: 10.1016/j.cbpb.2005.04.012
76. Fischmeister R, Castro LR, Abi-Gerges A, Rochais F, Jurevicius J, Leroy J, Vandecasteele G (2006) Compartmentation of cyclic nucleotide signaling in the heart: The role of cyclic nucleotide phosphodiesterases. Circ Res 99(8):816-828. doi: 10.1161/01. RES.0000246118.98832.04
77. Zhang M, Takimoto E, Lee DI, Santos CX, Nakamura T, Hsu S, Jiang A, Nagayama T, Bedja D, Yuan Y, Eaton P, Shah AM, Kass DA (2012) Pathological cardiac hypertrophy alters intracellular targeting of phosphodiesterase type 5 from nitric oxide synthase-3 to natriuretic Peptide signaling. Circulation 126(8):942-951
78. Jiang H, Colbran JL, Francis SH, Corbin JD (1992) Direct evidence for cross-activation of cGMP-dependent protein kinase by cAMP in pig coronary arteries. J Biol Chem 267(2):1015-1019
79. Kruger M, Kotter S, Grutzner A, Lang P, Andresen C, Redfield MM, Butt E, dos Remedios CG, Linke WA (2009) Protein kinase G modulates human myocardial passive stiffness by phosphorylation of the titin springs. Circ Res 104(1):87-94. doi: 10.1161/CIRCRESAHA.108.184408
80. LeWinter MM, Granzier H (2010) Cardiac titin: A multifunctional giant. Circulation 121(19):2137-2145. doi: 10.1161/CIRCULATIONAHA.109.860171
81. Voelkel T, Linke WA (2011) Conformationregulated mechanosensory control via titin domains in cardiac muscle. Pflugers Arch 462(1):143-154. doi: 10.1007/s00424-011-0938-1
82. Lee EJ, Peng J, Radke M, Gotthardt M, Granzier HL (2010) Calcium sensitivity and the Frank-Starling mechanism of the heart are increased in titin N2B region-deficient mice. J Mol Cell Cardiol 49(3):449-458. doi: 10.1016/j.yjmcc.2010.05.006
83. Terui T, Sodnomtseren M, Matsuba D, Udaka J, Ishiwata S, Ohtsuki I, Kurihara S, Fukuda N (2008) Troponin and titin coordinately regulate length-dependent activation in skinned porcine ventricular muscle. J Gen Physiol 131(3):275-283. doi: 10.1085/jgp.200709895
84. Borbely A, Falcao-Pires I, van Heerebeek L, Hamdani N, Edes I, Gavina C, Leite-Moreira AF, Bronzwaer JG, Papp Z, van der Velden J, Stienen GJ, Paulus WJ (2009) Hypophosphorylation of the Stiff N2B titin isoform raises cardiomyocyte resting tension in failing human myocardium. Circ Res 104(6):780-786. doi: 10.1161/CIRCRESAHA.108.193326
85. van Heerebeek L, Hamdani N, Falcao-Pires I, Leite-Moreira AF, Begieneman MP, Bronzwaer JG, van der Velden J, Stienen GJ, Laarman GJ, Somsen A, Verheugt FW, Niessen HW, Paulus WJ (2012) Low myocardial protein kinase g activity in heart failure with preserved ejection fraction. Circulation 126(7):830-839. doi: 10.1161/CIRCULATIONAHA.111.076075
86. Bishu K, Hamdani N, Mohammed SF, Kruger M, Ohtani T, Ogut O, Brozovich FV, Burnett JC Jr, Linke WA, Redfield MM (2011) Sildenafil and B-type natriuretic peptide acutely phosphorylate titin and improve diastolic distensibility in vivo. Circulation 124(25):2882-2891. doi: 10.1161/ CIRCULATIONAHA.111.048520
87. Kruger M, Linke WA (2006) Protein kinase-A phosphorylates titin in human heart muscle and reduces myofibrillar passive tension. J Muscle Res Cell Motil 27(5-7):435-444. doi: 10.1007/s10974-006-9090-5
88. Yamasaki R, Wu Y, McNabb M, Greaser M, Labeit S, Granzier H (2002) Protein kinase A phosphorylates titin's cardiac-specific N2B domain and reduces passive tension in rat cardiac myocytes. Circ Res 90(11):1181-1188
89. Jessup M, Brozena S (2003) Heart failure. N Engl J Med 348(20):2007-2018. doi: 10.1056/NEJMra021498
90. Zamanillo D, Sprengel R, Hvalby O, Jensen V, Burnashev N, Rozov A, Kaiser KM, Koster HJ, Borchardt T, Worley P, Lubke J, Frotscher M, Kelly PH, Sommer B, Andersen P, Seeburg PH, Sakmann B (1999) Importance of AMPA receptors for hippocampal synaptic plasticity but not for spatial learning. Science 284(5421):1805-1811
91. Shah AM, Mann DL (2011) In search of new therapeutic targets and strategies for heart failure: Recent advances in basic science. Lancet 378(9792):704-712. doi: 10.1016/S0140-6736(11)60894-5
92. John SW, Krege JH, Oliver PM, Hagaman JR, Hodgin JB, Pang SC, Flynn TG, Smithies O (1995) Genetic decreases in atrial natriuretic peptide and salt-sensitive hypertension. Science 267(5198):679-681
93. Oliver PM, Fox JE, Kim R, Rockman HA, Kim HS, Reddick RL, Pandey KN, Milgram SL, Smithies O, Maeda N (1997) Hypertension, cardiac hypertrophy, and sudden death in mice lacking natriuretic peptide receptor A. Proc Natl Acad Sci USA 94(26):14730-14735
94. Kishimoto I, Rossi K, Garbers DL (2001) A genetic model provides evidence that the receptor for atrial natriuretic peptide (guanylyl cyclase-A) inhibits cardiac ventricular myocyte hypertrophy. Proc Natl Acad Sci USA 98(5):2703-2706
95. Knowles JW, Esposito G, Mao L, Hagaman JR, Fox JE, Smithies O, Rockman HA, Maeda N (2001) Pressure-independent enhancement of cardiac hypertrophy in natriuretic peptide receptor A-deficient mice. J Clin Invest 107(8):975-984
96. Holtwick R, Van Eickels M, Skryabin BV, Baba HA, Bubikat A, Begrow F, Schneider MD, Garbers DL, Kuhn M (2003) Pressureindependent cardiac hypertrophy in mice with cardiomyocyte-restricted inactivation of the atrial natriuretic peptide receptor guanylyl cyclase-A. J Clin Invest 111(9):1399-1407
97. Ruetten H, Dimmeler S, Gehring D, Ihling C, Zeiher AM (2005) Concentric left ventricular remodeling in endothelial nitric oxide synthase knockout mice by chronic pressure overload. Cardiovasc Res 66(3):444-453. doi: 10.1016/j.cardiores.2005.01.021
98. Wenzel S, Rohde C, Wingerning S, Roth J, Kojda G, Schluter KD (2007) Lack of endothelial nitric oxide synthase-derived nitric oxide formation favors hypertrophy in adult ventricular cardiomyocytes. Hypertension 49(1):193-200. doi: 10.1161/01.HYP.0000250468.02084.ce
99. Flaherty MP, Brown M, Grupp IL, Schultz JE, Murphree SS, Jones WK (2007) eNOS deficient mice develop progressive cardiac hypertrophy with altered cytokine and calcium handling protein expression. Cardiovasc Toxicol 7(3):165-177. doi: 10.1007/s12012-007-0028-y\
100. Janssens S, Pokreisz P, Schoonjans L, Pellens M, Vermeersch P, Tjwa M, Jans P, Scherrer-Crosbie M, Picard MH, Szelid Z, Gillijns H, Van de Werf F, Collen D, Bloch KD (2004) Cardiomyocyte-specific overexpression of nitric oxide synthase 3 improves left ventricular performance and reduces compensatory hypertrophy after myocardial infarction. Circ Res 94(9):1256-1262. doi: 10.1161/01. RES.0000126497.38281.23
101. Calderone A, Thaik CM, Takahashi N, Chang DL, Colucci WS (1998) Nitric oxide, atrial natriuretic peptide, and cyclic GMP inhibit the growth-promoting effects of norepinephrine in cardiac myocytes andfibroblasts. J Clin Invest 101(4):812-818
102. Horio T, Nishikimi T, Yoshihara F, Matsuo H, Takishita S, Kangawa K (2000) Inhibitory regulation of hypertrophy by endogenous atrial natriuretic peptide in cultured cardiac myocytes. Hypertension 35(1 Pt 1):19-24
103. Laskowski A, Woodman OL, Cao AH, Drummond GR, Marshall T, Kaye DM, Ritchie RH (2006) Antioxidant actions contribute to the antihypertrophic effects of atrial natriuretic peptide in neonatal rat cardiomyocytes. Cardiovasc Res 72(1):112-123. doi: 10.1016/j.cardiores.2006.07.006
104. Nakamura TY, Iwata Y, Arai Y, Komamura K, Wakabayashi S (2008) Activation of Na + /H + exchanger 1 is sufficient to generate Ca 2+ signals that induce cardiac hypertrophy and heart failure. Circ Res 103(8):891-899. doi: 10.1161/CIRCRESAHA.108.175141
105. Nakayama H, Wilkin BJ, Bodi I, Molkentin JD (2006) Calcineurin-dependent cardiomyopathy is activated by TRPC in the adult mouse heart. FASEB J 20(10):1660-1670. doi: 10.1096/fj.05-5560com\\
106. De Windt LJ, Lim HW, Bueno OF, Liang Q, Delling U, Braz JC, Glascock BJ, Kimball TF, del Monte F, Hajjar RJ, Molkentin JD (2001) Targeted inhibition of calcineurin attenuates cardiac hypertrophy in vivo. Proc Natl Acad Sci USA 98(6):3322-3327. doi: 10.1073/pnas.031371998
107. Backs J, Backs T, Neef S, Kreusser MM, Lehmann LH, Patrick DM, Grueter CE, Qi X, Richardson JA, Hill JA, Katus HA, Bassel-Duby R, Maier LS, Olson EN (2009) The delta isoform of CaM kinase II is required for pathological cardiac hypertrophy and remodeling after pressure overload. Proc Natl Acad Sci USA 106(7):2342-2347. doi: 10.1073/pnas.0813013106
108. Condorelli G, Drusco A, Stassi G, Bellacosa A, Roncarati R, Iaccarino G, Russo MA, Gu Y, Dalton N, Chung C, Latronico MV, Napoli C, Sadoshima J, Croce CM, Ross J Jr (2002) Akt induces enhanced myocardial contractility and cell size in vivo in transgenic mice. Proc Natl Acad Sci USA 99(19):12333-12338. doi: 10.1073/pnas.172376399
109. Koitabashi N, Aiba T, Hesketh GG, Rowell J, Zhang M, Takimoto E, Tomaselli GF, Kass DA (2010) Cyclic GMP/PKG-dependent inhibition of TRPC6 channel activity and expression negatively regulates cardiomyocyte NFAT activation Novel mechanism of cardiac stress modulation by PDE5 inhibition. J Mol Cell Cardiol 48(4):713-724. doi: 10.1016/j. yjmcc.2009.11.015
110. Perez NG, Piaggio MR, Ennis IL, Garciarena CD, Morales C, Escudero EM, Cingolani OH, Chiappe de Cingolani G, Yang XP, Cingolani HE (2007) Phosphodiesterase 5A inhibition induces Na + /H + exchanger blockade and protection against myocardial infarction. Hypertension 49(5):1095-1103. doi: 10.1161/HYPERTENSIONAHA.107.087759
111. Yeves AM, Garciarena CD, Nolly MB, Chiappe de Cingolani GE, Cingolani HE, Ennis IL (2010) Decreased activity of the Na + /H + exchanger by phosphodiesterase 5A inhibition is attributed to an increase in protein phosphatase activity. Hypertension 56(4):690-695. doi: 10.1161/HYPERTENSIONAHA. 110.151324
112. Wollert KC, Fiedler B, Gambaryan S, Smolenski A, Heineke J, Butt E, Trautwein C, Lohmann SM, Drexler H (2002) Gene transfer of cGMP-dependent protein kinase I enhances the antihypertrophic effects of nitric oxide in cardiomyocytes. Hypertension 39(1):87-92
113. Fiedler B, Lohmann SM, Smolenski A, Linnemuller S, Pieske B, Schroder F, Molkentin JD, Drexler H, Wollert KC (2002) Inhibition of calcineurin-NFAT hypertrophy signaling by cGMP-dependent protein kinase type I in cardiac myocytes. Proc Natl Acad Sci USA 99(17):11363-11368
114. Hsu S, Nagayama T, Koitabashi N, Zhang M, Zhou L, Bedja D, Gabrielson KL, Molkentin JD, Kass DA, Takimoto E (2009) Phosphodiesterase 5 inhibition blocks pressure overload-induced cardiac hypertrophy independent of the calcineurin pathway. Cardiovasc Res 81(2):301-309. doi: 10.1093/cvr/cvn324
115. Das A, Xi L, Kukreja RC (2008) Protein kinase G-dependent cardioprotective mechanism of phosphodiesterase-5 inhibition involves phosphorylation of ERK and GSK3beta. J Biol Chem 283(43):29572-29585. doi: 10.1074/jbc.M801547200
116. Takimoto E, Koitabashi N, Hsu S, Ketner EA, Zhang M, Nagayama T, Bedja D, Gabrielson KL, Blanton R, Siderovski DP, Mendelsohn ME, Kass DA (2009) Regulator of G protein signaling 2 mediates cardiac compensation to pressure overload and antihypertrophic effects of PDE5 inhibition in mice. J Clin Invest 119(2):408-420. doi: 10.1172/JCI35620
117. Klaiber M, Kruse M, Volker K, Schroter J, Feil R, Freichel M, Gerling A, Feil S, Dietrich A, Londono JE, Baba HA, Abramowitz J, Birnbaumer L, Penninger JM, Pongs O, Kuhn M (2010) Novel insights into the mechanisms mediating the local antihypertrophic effects of cardiac atrial natriuretic peptide: Role of cGMP-dependent protein kinase and RGS2. Basic Res Cardiol 105(5):583-595. doi: 10.1007/s00395-010-0098-z
118. Garcia-Dorado D, Agullo L, Sartorio CL, Ruiz-Meana M (2009) Myocardial protection against reperfusion injury: The cGMP pathway. Thromb Haemost 101(4):635-642
119. Costa AD, Pierre SV, Cohen MV, Downey JM, Garlid KD (2008) cGMP signalling in pre- and post-conditioning: The role of mitochondria. Cardiovasc Res 77(2):344-352. doi: 10.1093/cvr/cvm050
120. Gorbe A, Giricz Z, Szunyog A, Csont T, Burley DS, Baxter GF, Ferdinandy P (2010) Role of cGMP-PKG signaling in the protection of neonatal rat cardiac myocytes subjected to simulated ischemia/reoxygenation. Basic Res Cardiol 105(5):643-650. doi: 10.1007/s00395-010-0097-0
121. Fiedler B, Feil R, Hofmann F, Willenbockel C, Drexler H, Smolenski A, Lohmann SM, Wollert KC (2006) cGMP-dependent protein kinase type I inhibits TAB1-p38 mitogenactivated protein kinase apoptosis signaling in cardiac myocytes. J Biol Chem 281(43):32831-32840. doi: 10.1074/jbc.M603416200
122. Costa AD, Garlid KD, West IC, Lincoln TM, Downey JM, Cohen MV, Critz SD (2005) Protein kinase G transmits the cardioprotective signal from cytosol to mitochondria. Circ Res 97(4):329-336. doi: 10.1161/01. RES.0000178451.08719.5b
123. Jang Y, Wang H, Xi J, Mueller RA, Nor fl eet EA, Xu Z (2007) NO mobilizes intracellular Zn 2+ via cGMP/PKG signaling pathway and prevents mitochondrial oxidant damage in cardiomyocytes. Cardiovasc Res 75(2): 426-433. doi: 10.1016/j.cardiores.2007.05.015
124. Li P, Wang D, Lucas J, Oparil S, Xing D, Cao X, Novak L, Renfrow MB, Chen YF (2008) Atrial natriuretic peptide inhibits transforming growth factor beta-induced Smad signaling and myofibroblast transformation in mouse cardiacfibroblasts. Circ Res 102(2):185-192. doi: 10.1161/CIRCRESAHA.107.157677
125. Murthy KS (2006) Signaling for contraction and relaxation in smooth muscle of the gut. Annu Rev Physiol 68:345-374. doi: 10.1146/annurev.physiol.68. 040504.094707
126. Frei E, Huster M, Smital P, Schlossmann J, Hofmann F, Wegener JW (2009) Calciumdependent and calcium-independent inhibition of contraction by cGMP/cGKI in intestinal smooth muscle. Am J Physiol Gastrointest Liver Physiol 297(4):G834-G839. doi: 10.1152/ajpgi.00095.2009
127. Koeppen M, Feil R, Siegl D, Feil S, Hofmann F, Pohl U, de Wit C (2004) cGMP-dependent protein kinase mediates NO- but not acetylcholine-induced dilations in resistance vessels in vivo. Hypertension 44(6):952-955
128. Pfeifer A, Klatt P, Massberg S, Ny L, Sausbier M, Hirneiss C, Wang GX, Korth M, Aszodi A, Andersson KE, Krombach F, Mayerhofer A, Ruth P, Fassler R, Hofmann F (1998) Defective smooth muscle regulation in cGMP kinase I-deficient mice. EMBO J 17(11):3045-3051
129. Sausbier M, Schubert R, Voigt V, Hirneiss C, Pfeifer A, Korth M, Kleppisch T, Ruth P, Hofmann F (2000) Mechanisms of NO/cGMP-dependent vasorelaxation. Circ Res 87(9):825-830
130. Weber S, Bernhard D, Lukowski R, Weinmeister P, Worner R, Wegener JW, Valtcheva N, Feil S, Schlossmann J, Hofmann F, Feil R (2007) Rescue of cGMP kinase I knockout mice by smooth muscle specific expression of either isozyme. Circ Res 101(11):1096-1103
131. Geiselhöringer A, Werner M, Sigl K, Smital P, Worner R, Acheo L, Stieber J, Weinmeister P, Feil R, Feil S, Wegener J, Hofmann F, Schlossmann J (2004) IRAG is essential for relaxation of receptor-triggered smooth muscle contraction by cGMP kinase. EMBO J 23(21):4222-4231
132. Hofmann F, Ammendola A, Schlossmann J (2000) Rising behind NO: CGMP-dependent protein kinases. J Cell Sci 113(Pt 10):1671-1676
133. Feil R, Gappa N, Rutz M, Schlossmann J, Rose CR, Konnerth A, Brummer S, Kuhbandner S, Hofmann F (2002) Functional reconstitution of vascular smooth muscle cells with cGMP-dependent protein kinase I isoforms. Circ Res 90(10):1080-1086
134. Geiselhöringer A, Gaisa M, Hofmann F, Schlossmann J (2004) Distribution of IRAG and cGKI-isoforms in murine tissues. FEBS Lett 575(1-3):19-22
135. Wolfe L, Corbin JD, Francis SH (1989) Characterization of a novel isozyme of cGMP-dependent protein kinase from bovine aorta. J Biol Chem 264(13):7734-7741
136. Morgado M, Cairrao E, Santos-Silva AJ, Verde I (2012) Cyclic nucleotide-dependent relaxation pathways in vascular smooth muscle. Cell Mol Life Sci 69(2):247-266. doi: 10.1007/s00018-011-0815-2
137. Vaandrager AB, de Jonge HR (1996) Signalling by cGMP-dependent protein kinases. Mol Cell Biochem 157(1-2):23-30
138. Tanaka Y, Tang G, Takizawa K, Otsuka K, Eghbali M, Song M, Nishimaru K, Shigenobu K, Koike K, Stefani E, Toro L (2006) Kv channels contribute to nitric oxide- and atrial natriuretic peptide-induced relaxation of a rat conduit artery. J Pharmacol Exp Ther 317(1):341-354. doi: 10.1124/jpet.105.096115
139. Rapoport RM (1986) Cyclic guanosine monophosphate inhibition of contraction may be mediated through inhibition of phosphatidylinositol hydrolysis in rat aorta. Circ Res 58(3):407-410
140. Xia C, Bao Z, Yue C, Sanborn BM, Liu M (2001) Phosphorylation and regulation of G-protein-activated phospholipase C-beta 3 by cGMP-dependent protein kinases. J Biol Chem 276(23):19770-19777
141. Hirata M, Kohse KP, Chang CH, Ikebe T, Murad F (1990) Mechanism of cyclic GMP inhibition of inositol phosphate formation in rat aorta segments and cultured bovine aortic smooth muscle cells. J Biol Chem 265(3):1268-1273
142. Hepler JR (1999) Emerging roles for RGS proteins in cell signalling. Trends Pharmacol Sci 20(9):376-382
143. Tang KM, Wang GR, Lu P, Karas RH, Aronovitz M, Heximer SP, Kaltenbronn KM, Blumer KJ, Siderovski DP, Zhu Y, Mendelsohn ME (2003) Regulator of G-protein signaling-2 mediates vascular smooth muscle relaxation and blood pressure. Nat Med 9(12): 1506-1512
144. Huang J, Zhou H, Mahavadi S, Sriwai W, Murthy KS (2007) Inhibition of Galphaqdependent PLC-beta1 activity by PKG and PKA is mediated by phosphorylation of RGS4 and GRK2. Am J Physiol Cell Physiol 292(1):C200-C208. doi: 10.1152/ajpcell.00103.2006
145. Pedram A, Razandi M, Kehrl J, Levin ER (2000) Natriuretic peptides inhibit G protein activation. Mediation through cross-talk between cyclic GMP-dependent protein kinase and regulators of G protein-signaling proteins. J Biol Chem 275(10):7365-7372
146. Sun X, Kaltenbronn KM, Steinberg TH, Blumer KJ (2005) RGS2 is a mediator of nitric oxide action on blood pressure and vasoconstrictor signaling. Mol Pharmacol 67(3):631-639
147. Wang GR, Zhu Y, Halushka PV, Lincoln TM, Mendelsohn ME (1998) Mechanism of platelet inhibition by nitric oxide: In vivo phosphorylation of thromboxane receptor by cyclic GMP-dependent protein kinase. Proc Natl Acad Sci USA 95(9):4888-4893
148. Klages B, Brandt U, Simon MI, Schultz G, Offermanns S (1999) Activation of G12/G13 results in shape change and Rho/Rhokinase-mediated myosin light chain phosphorylation in mouse platelets. J Cell Biol 144(4):745-754
149. Somlyo AP, Somlyo AV (2003) Ca 2+ sensitivity of smooth muscle and nonmuscle myosin II: Modulated by G proteins, kinases, and myosin phosphatase. Physiol Rev 83(4): 1325-1358
150. Komalavilas P, Lincoln TM (1994) Phosphorylation of the inositol 1,4,5-trisphosphate receptor by cyclic GMP-dependent protein kinase. J Biol Chem 269(12):8701-8707
151. Komalavilas P, Lincoln TM (1996) Phosphorylation of the inositol 1,4,5-trisphosphate receptor. Cyclic GMP-dependent protein kinase mediates cAMP and cGMP dependent phosphorylation in the intact rat aorta. J Biol Chem 271(36):21933-21938
152. Schlossmann J, Ammendola A, Ashman K, Zong X, Huber A, Neubauer G, Wang GX, Allescher HD, Korth M, Wilm M, Hofmann F, Ruth P (2000) Regulation of intracellular calcium by a signalling complex of IRAG, IP3 receptor and cGMP kinase Ibeta. Nature 404(6774):197-201
153. Ammendola A, Geiselhoringer A, Hofmann F, Schlossmann J (2001) Molecular determinants of the interaction between the inositol 1,4,5-trisphosphate receptor-associated cGMP kinase substrate (IRAG) and cGMP kinase Ibeta. J Biol Chem 276(26):24153-24159
154. Desch M, Sigl K, Hieke B, Salb K, Kees F, Bernhard D, Jochim A, Spiessberger B, Hocherl K, Feil R, Feil S, Lukowski R, Wegener JW, Hofmann F, Schlossmann J (2010) IRAG determines nitric oxide- and atrial natriuretic peptide-mediated smooth muscle relaxation. Cardiovasc Res 86(3):496-505. doi: 10.1093/cvr/cvq008
155. Welling A, Ludwig A, Zimmer S, Klugbauer N, Flockerzi V, Hofmann F (1997) Alternatively spliced IS6 segments of the alpha 1C gene determine the tissue-specific dihydropyridine sensitivity of cardiac and vascular smooth muscle l -type Ca 2+ channels. Circ Res 81(4):526-532
156. Lorenz JN, Bielefeld DR, Sperelakis N (1994) Regulation of calcium channel current in A7r5 vascular smooth muscle cells by cyclic nucleotides. Am J Physiol 266(6 Pt 1): C1656-C1663
157. Ruiz-Velasco V, Zhong J, Hume JR, Keef KD (1998) Modulation of Ca 2+ channels by cyclic nucleotide cross activation of opposing protein kinases in rabbit portal vein. Circ Res 82(5):557-565
158. Chen J, Crossland RF, Noorani MM, Marrelli SP (2009) Inhibition of TRPC1/TRPC3 by PKG contributes to NO-mediated vasorelaxation. Am J Physiol Heart Circ Physiol 297(1):H417-H424. doi: 10.1152/ajpheart.01130.2008
159. Inoue R, Okada T, Onoue H, Hara Y, Shimizu S, Naitoh S, Ito Y, Mori Y (2001) The transient receptor potential protein homologue TRP6 is the essential component of vascular alpha(1)-adrenoceptor-activated Ca (2+) -permeable cation channel. Circ Res 88(3):325-332
160. Koller A, Schlossmann J, Ashman K, Uttenweiler-Joseph S, Ruth P, Hofmann F (2003) Association of phospholamban with a cGMP kinase signaling complex. Biochem Biophys Res Commun 300(1):155-160
161. Raeymaekers L, Hofmann F, Casteels R (1988) Cyclic GMP-dependent protein kinase phosphorylates phospholamban in isolated sarcoplasmic reticulum from cardiac and smooth muscle. Biochem J 252(1):269-273
162. Lalli MJ, Shimizu S, Sutliff RL, Kranias EG, Paul RJ (1999) [Ca2+]i homeostasis and cyclic nucleotide relaxation in aorta of phospholamban-deficient mice. Am J Physiol 277(3 Pt 2):H963-H970
163. Cornwell TL, Pryzwansky KB, Wyatt TA, Lincoln TM (1991) Regulation of sarcoplasmic reticulum protein phosphorylation by localized cyclic GMP-dependent protein kinase in vascular smooth muscle cells. Mol Pharmacol 40(6):923-931
164. Kobayashi S, Kanaide H, Nakamura M (1985) Cytosolic-free calcium transients in cultured vascular smooth muscle cells: Micro fl uorometric measurements. Science 229(4713):553-556
165. Rashatwar SS, Cornwell TL, Lincoln TM (1987) Effects of 8-bromo-cGMP on Ca 2+ levels in vascular smooth muscle cells: Possible regulation of Ca 2+ -ATPase by cGMP-dependent protein kinase. Proc Natl Acad Sci USA 84(16):5685-5689
166. Vrolix M, Raeymaekers L, Wuytack F, Hofmann F, Casteels R (1988) Cyclic GMPdependent protein kinase stimulates the plasmalemmal Ca 2+ pump of smooth muscle via phosphorylation of phosphatidylinositol. Biochem J 255(3):855-863
167. Furukawa K, Nakamura H (1987) Cyclic GMP regulation of the plasma membrane (Ca 2+ -Mg 2+) ATPase in vascular smooth muscle. J Biochem 101(1):287-290
168. Furukawa K, Ohshima N, Tawada-Iwata Y, Shigekawa M (1991) Cyclic GMP stimulates Na + /Ca 2+ exchange in vascular smooth muscle cells in primary culture. J Biol Chem 266(19):12337-12341
169. Taniguchi J, Furukawa KI, Shigekawa M (1993) Maxi K + channels are stimulated by cyclic guanosine monophosphate-dependent protein kinase in canine coronary artery smooth muscle cells. Pflugers Arch 423(3-4):167-172
170. Robertson BE, Schubert R, Hescheler J, Nelson MT (1993) cGMP-dependent protein kinase activates Ca-activated K channels in cerebral artery smooth muscle cells. Am J Physiol 265(1 Pt 1):C299-C303
171. Alioua A, Tanaka Y, Wallner M, Hofmann F, Ruth P, Meera P, Toro L (1998) The large conductance, voltage-dependent, and calcium-sensitive K + channel, Hslo, is a target of cGMP-dependent protein kinase phosphorylation in vivo. J Biol Chem 273(49): 32950-32956
172. Bolotina VM, Najibi S, Palacino JJ, Pagano PJ, Cohen RA (1994) Nitric oxide directly activates calcium-dependent potassium channels in vascular smooth muscle. Nature 368(6474):850-853. doi: 10.1038/368850a0
173. Fukao M, Mason HS, Britton FC, Kenyon JL, Horowitz B, Keef KD (1999) Cyclic GMP-dependent protein kinase activates cloned BKCa channels expressed in mammalian cells by direct phosphorylation at serine 1072. J Biol Chem 274(16):10927-10935
174. Zhou XB, Ruth P, Schlossmann J, Hofmann F, Korth M (1996) Protein phosphatase 2A is essential for the activation of Ca 2+ -activated K + currents by cGMP-dependent protein kinase in tracheal smooth muscle and Chinese hamster ovary cells. J Biol Chem 271(33):19760-19767
175. White RE, Lee AB, Shcherbatko AD, Lincoln TM, Schonbrunn A, Armstrong DL (1993) Potassium channel stimulation by natriuretic peptides through cGMP-dependent dephosphorylation. Nature 361(6409):263-266
176. Surks HK, Mochizuki N, Kasai Y, Georgescu SP, Tang KM, Ito M, Lincoln TM, Mendelsohn ME (1999) Regulation of myosin phosphatase by a specific interaction with cGMP-dependent protein kinase Ialpha. Science 286(5444):1583-1587
177. Wooldridge AA, MacDonald JA, Erdodi F, Ma C, Borman MA, Hartshorne DJ, Haystead TA (2004) Smooth muscle phosphatase is regulated in vivo by exclusion of phosphorylation of threonine 696 of MYPT1 by phosphorylation of Serine 695 in response to cyclic nucleotides. J Biol Chem 279(33):34496-34504
178. Lee MR, Li L, Kitazawa T (1997) Cyclic GMP causes Ca 2+ desensitization in vascular smooth muscle by activating the myosin light chain phosphatase. J Biol Chem 272(8):5063-5068
179. Nakamura K, Koga Y, Sakai H, Homma K, Ikebe M (2007) cGMP-dependent relaxation of smooth muscle is coupled with the change in the phosphorylation of myosin phosphatase. Circ Res 101(7):712-722. doi: 10.1161/CIRCRESAHA.107.153981
180. Somlyo AV (2007) Cyclic GMP regulation of myosin phosphatase: A new piece for the puzzle? Circ Res 101(7):645-647. doi: 10.1161/CIRCRESAHA.107.161893
181. Khromov AS, Wang H, Choudhury N, McDuffie M, Herring BP, Nakamoto R, Owens GK, Somlyo AP, Somlyo AV (2006) Smooth muscle of telokin-deficient mice exhibits increased sensitivity to Ca 2+ and decreased cGMP-induced relaxation. Proc Natl Acad Sci USA 103(7):2440-2445. doi: 10.1073/pnas.0508566103
182. Borman MA, MacDonald JA, Haystead TA (2004) Modulation of smooth muscle contractility by CHASM, a novel member of the smoothelin family of proteins. FEBS Lett 573(1-3):207-213. doi: 10.1016/j. febslet.2004.08.002
183. Sauzeau V, Le Jeune H, Cario-Toumaniantz C, Smolenski A, Lohmann SM, Bertoglio J, Chardin P, Pacaud P, Loirand G (2000) Cyclic GMP-dependent protein kinase signaling pathway inhibits RhoA-induced Ca 2+ sensitization of contraction in vascular smooth muscle. J Biol Chem 275(28):21722-21729
184. Loirand G, Guerin P, Pacaud P (2006) Rho kinases in cardiovascular physiology and pathophysiology. Circ Res 98(3):322-334. doi: 10.1161/01.RES.0000201960.04223.3c
185. Sakurada S, Takuwa N, Sugimoto N, Wang Y, Seto M, Sasaki Y, Takuwa Y (2003) Ca2+-dependent activation of Rho and Rho kinase in membrane depolarization-induced and receptor stimulation-induced vascular smooth muscle contraction. Circ Res 93(6):548-556. doi: 10.1161/01.RES.0000090998.08629.60
186. Bonnevier J, Arner A (2004) Actions downstream of cyclic GMP/protein kinase G can reverse protein kinase C-mediated phosphorylation of CPI-17 and Ca(2+) sensitization in smooth muscle. J Biol Chem 279(28):28998-29003
187. Woodrum DA, Brophy CM, Wingard CJ, Beall A, Rasmussen H (1999) Phosphorylation events associated with cyclic nucleotidedependent inhibition of smooth muscle contraction. Am J Physiol 277(3 Pt 2): H931-H939
188. Rembold CM, Foster DB, Strauss JD, Wingard CJ, Eyk JE (2000) cGMP-mediated phosphorylation of heat shock protein 20 may cause smooth muscle relaxation without myosin light chain dephosphorylation in swine carotid artery. J Physiol 524(Pt 3): 865-878
189. Woodrum D, Pipkin W, Tessier D, Komalavilas P, Brophy CM (2003) Phosphorylation of the heat shock-related protein, HSP20, mediates cyclic nucleotide-dependent relaxation. J Vasc Surg 37(4):874-881. doi: 10.1067/mva.2003.153
190. Essin K, Welling A, Hofmann F, Luft FC, Gollasch M, Moosmang S (2007) Indirect coupling between Cav1.2 channels and ryanodine receptors to generate Ca 2+ sparks in murine arterial smooth muscle cells. J Physiol 584(Pt 1):205-219
191. Moosmang S, Schulla V, Welling A, Feil R, Feil S, Wegener JW, Hofmann F, Klugbauer N (2003) Dominant role of smooth muscle l -type calcium channel Cav1.2 for blood pressure regulation. EMBO J 22(22):6027-6034
192. Wegener JW, Schulla V, Lee TS, Koller A, Feil S, Feil R, Kleppisch T, Klugbauer N, Moosmang S, Welling A, Hofmann F (2004) An essential role of Cav1.2 l -type calcium channel for urinary bladder function. FASEB J 18(10):1159-1161
193. Huang PL, Huang Z, Mashimo H, Bloch KD, Moskowitz MA, Bevan JA, Fishman MC (1995) Hypertension in mice lacking the gene for endothelial nitric oxide synthase. Nature 377(6546):239-242
194. Kuhn M (2005) Cardiac and intestinal natriuretic peptides: Insights from genetically modified mice. Peptides 26(6):1078-1085
195. Sausbier M, Arntz C, Bucurenciu I, Zhao H, Zhou XB, Sausbier U, Feil S, Kamm S, Essin K, Sailer CA, Abdullah U, Krippeit-Drews P, Feil R, Hofmann F, Knaus HG, Kenyon C, Shipston MJ, Storm JF, Neuhuber W, Korth M, Schubert R, Gollasch M, Ruth P (2005) Elevated blood pressure linked to primary hyperaldosteronism and impaired vasodilation in BK channeldeficient mice. Circulation 112(1):60-68. doi: 10.1161/01.CIR.0000156448.74296.FE
196. Faraci FM, Sigmund CD (1999) Vascular biology in genetically altered mice: Smaller vessels, bigger insight. Circ Res 85(12):1214-1225
197. Murata T, Ushikubi F, Matsuoka T, Hirata M, Yamasaki A, Sugimoto Y, Ichikawa A, Aze Y, Tanaka T, Yoshida N, Ueno A, Oh-ishi S, Narumiya S (1997) Altered pain perception and in fl ammatory response in mice lacking prostacyclin receptor. Nature 388(6643): 678-682. doi: 10.1038/41780
198. Meng W, Ayata C, Waeber C, Huang PL, Moskowitz MA (1998) Neuronal NOScGMP-dependent ACh-induced relaxation in pial arterioles of endothelial NOS knockout mice. Am J Physiol 274(2 Pt 2): H411-H415
199. Friebe A, Mergia E, Dangel O, Lange A, Koesling D (2007) Fatal gastrointestinal obstruction and hypertension in mice lacking nitric oxide-sensitive guanylyl cyclase. Proc Natl Acad Sci USA 104(18):7699-7704
200. Landgraf W, Regulla S, Meyer HE, Hofmann F (1991) Oxidation of cysteines activates cGMP-dependent protein kinase. J Biol Chem 266(25):16305-16311
201. Osborne BW, Wu J, McFarland CJ, Nickl CK, Sankaran B, Casteel DE, Woods VL Jr, Kornev AP, Taylor SS, Dostmann WR (2011) Crystal structure of cGMP-dependent protein kinase reveals novel site of interchain communication. Structure 19(9):1317-1327
202. Burgoyne JR, Madhani M, Cuello F, Charles RL, Brennan JP, Schroder E, Browning DD, Eaton P (2007) Cysteine redox sensor in PKGIa enables oxidant-induced activation. Science 317(5843):1393-1397
203. Prysyazhna O, Rudyk O, Eaton P (2012) Single atom substitution in mouse protein kinase G eliminates oxidant sensing to cause hypertension. Nat Med 18(2):286-290
204. Ozaki M, Kawashima S, Yamashita T, Hirase T, Namiki M, Inoue N, Hirata K, Yasui H, Sakurai H, Yoshida Y, Masada M, Yokoyama M (2002) Overexpression of endothelial nitric oxide synthase accelerates atherosclerotic lesion formation in apoE-deficient mice. J Clin Invest 110(3):331-340
205. Kuhlencordt PJ, Chen J, Han F, Astern J, Huang PL (2001) Genetic deficiency of inducible nitric oxide synthase reduces atherosclerosis and lowers plasma lipid peroxides in apolipoprotein E-knockout mice. Circulation 103(25):3099-3104
206. Chyu KY, Dimayuga P, Zhu J, Nilsson J, Kaul S, Shah PK, Cercek B (1999) Decreased neointimal thickening after arterial wall injury in inducible nitric oxide synthase knockout mice. Circ Res 85(12):1192-1198
207. Tolbert T, Thompson JA, Bouchard P, Oparil S (2001) Estrogen-induced vasoprotection is independent of inducible nitric oxide synthase expression: Evidence from the mouse carotid artery ligation model. Circulation 104(22):2740-2745
208. Detmers PA, Hernandez M, Mudgett J, Hassing H, Burton C, Mundt S, Chun S, Fletcher D, Card DJ, Lisnock J, Weikel R, Bergstrom JD, Shevell DE, Hermanowski-Vosatka A, Sparrow CP, Chao YS, Rader DJ, Wright SD, Pure E (2000) Deficiency in inducible nitric oxide synthase results in reduced atherosclerosis in apolipoprotein E-deficient mice. J Immunol 165(6):3430-3435
209. Sennlaub F, Courtois Y, Goureau O (2001) Inducible nitric oxide synthase mediates the change from retinal to vitreal neovascularization in ischemic retinopathy. J Clin Invest 107(6):717-725
210. Knowles JW, Reddick RL, Jennette JC, Shesely EG, Smithies O, Maeda N (2000) Enhanced atherosclerosis and kidney dysfunction in eNOS(-/-)Apoe(-/-) mice are ameliorated by enalapril treatment. J Clin Invest 105(4):451-458
211. Kuhlencordt PJ, Gyurko R, Han F, Scherrer-Crosbie M, Aretz TH, Hajjar R, Picard MH, Huang PL (2001) Accelerated atherosclerosis, aortic aneurysm formation, and ischemic heart disease in apolipoprotein E/endothelial nitric oxide synthase double-knockout mice. Circulation 104(4):448-454
212. Moroi M, Zhang L, Yasuda T, Virmani R, Gold HK, Fishman MC, Huang PL (1998) Interaction of genetic deficiency of endothelial nitric oxide, gender, and pregnancy in vascular response to injury in mice. J Clin Invest 101(6):1225-1232
213. Rudic RD, Shesely EG, Maeda N, Smithies O, Segal SS, Sessa WC (1998) Direct evidence for the importance of endothelium-derived nitric oxide in vascular remodeling. J Clin Invest 101(4):731-736
214. Chen J, Kuhlencordt PJ, Astern J, Gyurko R, Huang PL (2001) Hypertension does not account for the accelerated atherosclerosis and development of aneurysms in male apolipoprotein e/endothelial nitric oxide synthase double knockout mice. Circulation 104(20): 2391-2394
215. Koglin J, Glysing-Jensen T, Mudgett JS, Russell ME (1998) Exacerbated transplant arterioscle rosis in inducible nitric oxide- deficient mice. Circulation 97(20):2059-2065
216. Lablanche JM, Grollier G, Lusson JR, Bassand JP, Drobinski G, Bertrand B, Battaglia S, Desveaux B, Juilliere Y, Juliard JM, Metzger JP, Coste P, Quiret JC, Dubois-Rande JL, Crochet PD, Letac B, Boschat J, Virot P, Finet G, Le Breton H, Livarek B, Leclercq F, Beard T, Giraud T, Bertrand ME et al (1997) Effect of the direct nitric oxide donors linsidomine and molsidomine on angiographic restenosis after coronary balloon angioplasty. The ACCORD study. angioplastic coronaire corvasal diltiazem. Circulation 95(1):83-89
217. Poon BY, Raharjo E, Patel KD, Tavener S, Kubes P (2003) Complexity of inducible nitric oxide synthase: Cellular source determines benefit versus toxicity. Circulation 108(9):1107-1112
218. Berk BC (2001) Vascular smooth muscle growth: Autocrine growth mechanisms. Physiol Rev 81(3):999-1030
219. Dzau VJ, Braun-Dullaeus RC, Sedding DG (2002) Vascular proliferation and atherosclerosis: New perspectives and therapeutic strategies. Nat Med 8(11):1249-1256
220. Owens GK, Kumar MS, Wamhoff BR (2004) Molecular regulation of vascular smooth muscle cell differentiation in development and disease. Physiol Rev 84(3):767-801
221. Schwartz SM, deBlois D, O'Brien ER (1995) The intima. Soil for atherosclerosis and restenosis. Circ Res 77(3):445-465
222. Hofmann F, Feil R, Kleppisch T, Schlossmann J (2006) Function of cGMP-dependent protein kinases as revealed by gene deletion. Physiol Rev 86(1):1-23
223. Weinmeister P, Lukowski R, Linder S, Traidl-Hoffmann C, Hengst L, Hofmann F, Feil R (2008) Cyclic guanosine monophosphatedependent protein kinase I promotes adhesion of primary vascular smooth muscle cells. Mol Biol Cell 19(10):4434-4441. doi: 10.1091/mbc.E08-04-0370
224. Eigenthaler M, Lohmann SM, Walter U, Pilz RB (1999) Signal transduction by cGMPdependent protein kinases and their emerging roles in the regulation of cell adhesion and gene expression. Rev Physiol Biochem Pharmacol 135:173-209
225. Lincoln TM, Dey N, Sellak H (2001) Invited review: CGMP-dependent protein kinase signaling mechanisms in smooth muscle: From the regulation of tone to gene expression. J Appl Physiol 91(3):1421-1430
226. Pilz RB, Casteel DE (2003) Regulation of gene expression by cyclic GMP. Circ Res 93(11):1034-1046
227. Lincoln TM, Wu X, Sellak H, Dey N, Choi CS (2006) Regulation of vascular smooth muscle cell phenotype by cyclic GMP and cyclic GMP-dependent protein kinase. Front Biosci 11:356-367
228. Kawai-Kowase K, Owens GK (2007) Multiple repressor pathways contribute to phenotypic switching of vascular smooth muscle cells. Am J Physiol Cell Physiol 292(1):C59-C69
229. Cornwell TL, Arnold E, Boerth NJ, Lincoln TM (1994) Inhibition of smooth muscle cell growth by nitric oxide and activation of cAMP-dependent protein kinase by cGMP. Am J Physiol 267(5 Pt 1):C1405-C1413
230. Boerth NJ, Dey NB, Cornwell TL, Lincoln TM (1997) Cyclic GMP-dependent protein kinase regulates vascular smooth muscle cell phenotype. J Vasc Res 34(4):245-259
231. Negash S, Narasimhan SR, Zhou W, Liu J, Wei FL, Tian J, Raj JU (2009) Role of cGMPdependent protein kinase in regulation of pulmonary vascular smooth muscle cell adhesion and migration: Effect of hypoxia. Am J Physiol Heart Circ Physiol 297(1):H304-H312. doi: 10.1152/ajpheart.00077.2008
232. Pauly RR, Passaniti A, Bilato C, Monticone R, Cheng L, Papadopoulos N, Gluzband YA, Smith L, Weinstein C, Lakatta EG et al (1994) Migration of cultured vascular smooth muscle cells through a basement membrane barrier requires type IV collagenase activity and is inhibited by cellular differentiation. Circ Res 75(1):41-54
233. Bendeck MP, Irvin C, Reidy MA (1996) Inhibition of matrix metalloproteinase activity inhibits smooth muscle cell migration but not neointimal thickening after arterial injury. Circ Res 78(1):38-43
234. Dey NB, Lincoln TM (2012) Possible involvement of cyclic-GMP-dependent protein kinase on matrix metalloproteinase-2 expression in rat aortic smooth muscle cells. Mol Cell Biochem 368(1-2):27-35. doi: 10.1007/s11010-012-1339-2
235. Liu N, Olson EN (2006) Coactivator control of cardiovascular growth and remodeling. Curr Opin Cell Biol 18(6):715-722
236. Huber A, Neuhuber WL, Klugbauer N, Ruth P, Allescher HD (2000) Cysteine-rich protein 2, a novel substrate for cGMP kinase I in enteric neurons and intestinal smooth muscle. J Biol Chem 275(8):5504-5511
237. Karim MA, Ohta K, Egashira M, Jinno Y, Niikawa N, Matsuda I, Indo Y (1996) Human ESP1/CRP2, a member of the LIM domain protein family: Characterization of the cDNA and assignment of the gene locus to chromosome 14q32.3. Genomics 31(2):167-176
238. Okano I, Yamamoto T, Kaji A, Kimura T, Mizuno K, Nakamura T (1993) Cloning of CRP2, a novel member of the cysteine-rich protein family with two repeats of an unusual LIM/double zinc-finger motif. FEBS Lett 333(1-2):51-55
239. Zhang T, Zhuang S, Casteel DE, Looney DJ, Boss GR, Pilz RB (2007) A cysteine-rich LIM-only protein mediates regulation of smooth muscle-specific gene expression by cGMP-dependent protein kinase. J Biol Chem 282(46):33367-33380
240. Schmidtko A, Gao W, Sausbier M, Rauhmeier I, Sausbier U, Niederberger E, Scholich K, Huber A, Neuhuber W, Allescher HD, Hofmann F, Tegeder I, Ruth P, Geisslinger G (2008) Cysteine-rich protein 2, a novel downstream effector of cGMP/cGMP-dependent protein kinase I-mediated persistent in fl ammatory pain. J Neurosci 28(6):1320-1330. doi: 10.1523/JNEUROSCI.5037-07.2008
241. Sinnaeve P, Chiche JD, Gillijns H, Van Pelt N, Wirthlin D, Van De Werf F, Collen D, Bloch KD, Janssens S (2002) Overexpression of a constitutively active protein kinase G mutant reduces neointima formation and in-stent restenosis. Circulation 105(24):2911-2916
242. Lukowski R, Weinmeister P, Bernhard D, Feil S, Gotthardt M, Herz J, Massberg S, Zernecke A, Weber C, Hofmann F, Feil R (2008) Role of smooth muscle cGMP/cGKI signaling in murine vascular restenosis. Arterioscler Thromb Vasc Biol 28(7):1244-1250. doi: 10.1161/ATVBAHA.108.166405
243. Werner C, Raivich G, Cowen M, Strekalova T, Sillaber I, Buters JT, Spanagel R, Hofmann F (2004) Importance of NO/cGMP signalling via cGMP-dependent protein kinase II for controlling emotionality and neurobehavioural effects of alcohol. Eur J Neurosci 20(12):3498-3506
244. el-Husseini AE, Bladen C, Vincent SR (1995) Molecular characterization of a type II cyclic GMP-dependent protein kinase expressed in the rat brain. J Neurochem 64(6):2814-2817
245. Feil S, Zimmermann P, Knorn A, Brummer S, Schlossmann J, Hofmann F, Feil R (2005) Distribution of cGMP-dependent protein kinase type I and its isoforms in the mouse brain and retina. Neuroscience 135(3):863-868
246. Singh AK, Spiessberger B, Zheng W, Xiao F, Lukowski R, Wegener JW, Weinmeister P, Saur D, Klein S, Schemann M, Krueger D, Seidler U, Hofmann F (2012) Neuronal cGMP kinase I is essential for stimulation of duodenal bicarbonate secretion by luminal acid. FASEB J 26(4):1745-1754
247. Paul C, Schoberl F, Weinmeister P, Micale V, Wotjak CT, Hofmann F, Kleppisch T (2008) Signaling through cGMP-dependent protein kinase I in the amygdala is critical for auditory-cued fear memory and long-term potentiation. J Neurosci 28(52): 14202-14212
248. Oster H, Werner C, Magnone MC, Mayser H, Feil R, Seeliger MW, Hofmann F, Albrecht U (2003) cGMP-dependent protein kinase II modulates mPer1 and mPer2 gene induction and in fl uences phase shifts of the circadian clock. Curr Biol 13(9):725-733
249. Revermann M, Maronde E, Ruth P, Korf HW (2002) Protein kinase G I immunoreaction is colocalized with arginine-vasopressin immunoreaction in the rat suprachiasmatic nucleus. Neurosci Lett 334(2):119-122
250. Weber ET, Gannon RL, Rea MA (1995) cGMP-dependent protein kinase inhibitor blocks light-induced phase advances of circadian rhythms in vivo. Neurosci Lett 197(3):227-230
251. Mathur A, Golombek DA, Ralph MR (1996) cGMP-dependent protein kinase inhibitors block light-induced phase advances of circadian rhythms in vivo. Am J Physiol 270 (5 Pt 2):R1031-R1036
252. Tischkau SA, Mitchell JW, Pace LA, Barnes JW, Barnes JA, Gillette MU (2004) Protein kinase G type II is required for night-to-day progression of the mammalian circadian clock. Neuron 43(4):539-549
253. Langmesser S, Franken P, Feil S, Emmenegger Y, Albrecht U, Feil R (2009) cGMP-dependent protein kinase type I is implicated in the regulation of the timing and quality of sleep and wakefulness. PLoS One 4(1):e4238
254. Sold G, Hofmann F (1974) Evidence for a guanosine-3 ¢ :5 ¢ -monophosphate-binding protein from rat cerebellum. Eur J Biochem 44(1):143-149
255. Lohmann SM, Walter U, Miller PE, Greengard P, De Camilli P (1981) Immunohistochemical localization of cyclic GMP-dependent protein kinase in mammalian brain. Proc Natl Acad Sci USA 78(1):653-657
256. Li Z, Xi X, Gu M, Feil R, Ye RD, Eigenthaler M, Hofmann F, Du X (2003) A stimulatory role for cGMP-dependent protein kinase in platelet activation. Cell 112(1):77-86
257. Kleppisch T, Pfeifer A, Klatt P, Ruth P, Montkowski A, Fassler R, Hofmann F (1999) Long-term potentiation in the hippocampal CA1 region of mice lacking cGMP-dependent kinases is normal and susceptible to inhibition of nitric oxide synthase. J Neurosci 19(1): 48-55
258. Kleppisch T, Wolfsgruber W, Feil S, Allmann R, Wotjak CT, Goebbels S, Nave KA, Hofmann F, Feil R (2003) Hippocampal cGMP-dependent protein kinase I supports an age- and protein synthesis-dependent component of long-term potentiation but is not essential for spatial reference and contextual memory. J Neurosci 23(14):6005-6012
259. Arancio O, Antonova I, Gambaryan S, Lohmann SM, Wood JS, Lawrence DS, Hawkins RD (2001) Presynaptic role of cGMP-dependent protein kinase during long-lasting potentiation. J Neurosci 21(1): 143-149
260. Song H, Ming G, He Z, Lehmann M, McKerracher L, Tessier-Lavigne M, Poo M (1998) Conversion of neuronal growth cone responses from repulsion to attraction by cyclic nucleotides. Science 281(5382): 1515-1518
261. Schmidt H, Werner M, Heppenstall PA, Henning M, More MI, Kuhbandner S, Lewin GR, Hofmann F, Feil R, Rathjen FG (2002) cGMP-mediated signaling via cGKIalpha is required for the guidance and connectivity of sensory axons. J Cell Biol 159(3):489-498
262. Schmidt H, Stonkute A, Juttner R, Schaffer S, Buttgereit J, Feil R, Hofmann F, Rathjen FG (2007) The receptor guanylyl cyclase Npr2 is essential for sensory axon bifurcation within the spinal cord. J Cell Biol 179(2):331-340
263. Tegeder I, Del Turco D, Schmidtko A, Sausbier M, Feil R, Hofmann F, Deller T, Ruth P, Geisslinger G (2004) Reduced in fl ammatory hyperalgesia with preservation of acute thermal nociception in mice lacking cGMP-dependent protein kinase I. Proc Natl Acad Sci USA 101(9):3253-3257
264. Luo C, Gangadharan V, Bali KK, Xie RG, Agarwal N, Kurejova M, Tappe-Theodor A, Tegeder I, Feil S, Lewin G, Polgar E, Todd AJ, Schlossmann J, Hofmann F, Liu DL, Hu SJ, Feil R, Kuner T, Kuner R (2012) Presynaptically localized cyclic GMPdependent protein kinase 1 is a key determinant of spinal synaptic potentiation and pain hypersensitivity. PLoS Biol 10(3):e1001283
265. Pfeifer A, Aszodi A, Seidler U, Ruth P, Hofmann F, Fassler R (1996) Intestinal secretory defects and dwarfism in mice lacking cGMP- dependent protein kinase II. Science 274(5295):2082-2086
266. Vaandrager AB, Smolenski A, Tilly BC, Houtsmuller AB, Ehlert EM, Bot AG, Edixhoven M, Boomaars WE, Lohmann SM, de Jonge HR (1998) Membrane targeting of cGMP-dependent protein kinase is required for cysticfibrosis transmembrane conductance regulator Cl- channel activation. Proc Natl Acad Sci USA 95(4):1466-1471
267. Vaandrager AB, Bot AG, Ruth P, Pfeifer A, Hofmann F, De Jonge HR (2000) Differential role of cyclic GMP-dependent protein kinase II in ion transport in murine small intestine and colon. Gastroenterology 118(1):108-114
268. Cha B, Kim JH, Hut H, Hogema BM, Nadarja J, Zizak M, Cavet M, Lee-Kwon W, Lohmann SM, Smolenski A, Tse CM, Yun C, de Jonge HR, Donowitz M (2005) cGMP inhibition of Na+/H+ antiporter 3 (NHE3) requires PDZ domain adapter NHERF2, a broad specificity protein kinase G-anchoring protein. J Biol Chem 280(17):16642-50
269. Foller M, Feil S, Ghoreschi K, Koka S, Gerling A, Thunemann M, Hofmann F, Schuler B, Vogel J, Pichler B, Kasinathan RS, Nicolay JP, Huber SM, Lang F, Feil R (2008) Anemia and splenomegaly in cGKI-deficient mice. Proc Natl Acad Sci USA 105(18):6771-6776. doi: 10.1073/pnas.0708940105
270. Nikolaev VO, Gambaryan S, Engelhardt S, Walter U, Lohse MJ (2005) Real-time monitoring of the PDE2 activity of live cells: Hormone-stimulated cAMP hydrolysis is faster than hormone-stimulated cAMP synthesis. J Biol Chem 280(3):1716-1719
271. MacFarland RT, Zelus BD, Beavo JA (1991) High concentrations of a cGMP-stimulated phosphodiesterase mediate ANP-induced decreases in cAMP and steroidogenesis in adrenal glomerulosa cells. J Biol Chem 266(1):136-142
272. Kurtz A, Gotz KH, Hamann M, Wagner C (1998) Stimulation of renin secretion by nitric oxide is mediated by phosphodiesterase 3. Proc Natl Acad Sci USA 95(8):4743-4747
273. Henrich WL, McAllister EA, Smith PB, Campbell WB (1988) Guanosine 3 ¢, 5 ¢ -cyclic monophosphate as a mediator of inhibition of renin release. Am J Physiol 255(3 Pt 2): F474-F478
274. Schricker K, Kurtz A (1993) Liberators of NO exert a dual effect on renin secretion from isolated mouse renal juxtaglomerular cells. Am J Physiol 265(2 Pt 2):F180-F186
275. Gambaryan S, Hausler C, Markert T, Pohler D, Jarchau T, Walter U, Haase W, Kurtz A, Lohmann SM (1996) Expression of type II cGMP-dependent protein kinase in rat kidney is regulated by dehydration and correlated with renin gene expression. J Clin Invest 98(3):662-670
276. Wagner C, Pfeifer A, Ruth P, Hofmann F, Kurtz A (1998) Role of cGMP-kinase II in the control of renin secretion and renin expression. J Clin Invest 102(8):1576-1582
277. Gambaryan S, Butt E, Marcus K, Glazova M, Palmetshofer A, Guillon G, Smolenski A (2003) cGMP-dependent protein kinase type II regulates basal level of aldosterone production by zona glomerulosa cells without increasing expression of the steroidogenic acute regulatory protein gene. J Biol Chem 278(32):29640-29648
278. Spiessberger B, Bernhard D, Herrmann S, Feil S, Werner C, Luppa PB, Hofmann F (2009) cGMP-dependent protein kinase II and aldosterone secretion. FEBS J 276(4): 1007-1013
279. Schinner E, Hofmann F, Schlossmann J (2012) Role of cGMP-dependent protein kinase I for kidneyfibrosis. N-Schmied Arch Pharmacol 385(Suppl1):S81
280. Chusho H, Tamura N, Ogawa Y, Yasoda A, Suda M, Miyazawa T, Nakamura K, Nakao K, Kurihara T, Komatsu Y, Itoh H, Tanaka K, Saito Y, Katsuki M (2001) Dwarfism and early death in mice lacking C-type natriuretic peptide. Proc Natl Acad Sci USA 98(7):4016-4021
281. Yasoda A, Komatsu Y, Chusho H, Miyazawa T, Ozasa A, Miura M, Kurihara T, Rogi T, Tanaka S, Suda M, Tamura N, Ogawa Y, Nakao K (2004) Overexpression of CNP in chondrocytes rescues achondroplasia through a MAPK-dependent pathway. Nat Med 10(1):80-86
282. Talts JF, Pfeifer A, Hofmann F, Hunziker EB, Zhou XH, Aszodi A, Fassler R (1998) Endochondral ossi fication is dependent on the mechanical properties of cartilage tissue and on intracellular signals in chondrocytes. Ann N Y Acad Sci 857:74-85
283. Miyazawa T, Ogawa Y, Chusho H, Yasoda A, Tamura N, Komatsu Y, Pfeifer A, Hofmann F, Nakao K (2002) Cyclic GMP-dependent protein kinase II plays a critical role in C-type natriuretic peptide-mediated endochondral ossi fication. Endocrinology 143(9):3604-3610
284. Nakano Y, Nagamatsu Y, Ohshima Y (2004) cGMP and a germ-line signal control body size in C. elegans through cGMP-dependent protein kinase EGL-4. Genes Cells 9(9):773-779
285. Chikuda H, Kugimiya F, Hoshi K, Ikeda T, Ogasawara T, Shimoaka T, Kawano H, Kamekura S, Tsuchida A, Yokoi N, Nakamura K, Komeda K, Chung UI, Kawaguchi H (2004) Cyclic GMP-dependent protein kinase II is a molecular switch from proliferation to hypertrophic differentiation of chondrocytes. Genes Dev 18(19):2418-2429
286. Zhao X, Zhuang S, Chen Y, Boss GR, Pilz RB (2005) Cyclic GMP-dependent protein kinase regulates CCAAT enhancer-binding protein beta functions through inhibition of glycogen synthase kinase-3. J Biol Chem 280(38): 32683-32692
287. Kawasaki Y, Kugimiya F, Chikuda H, Kamekura S, Ikeda T, Kawamura N, Saito T, Shinoda Y, Higashikawa A, Yano F, Ogasawara T, Ogata N, Hoshi K, Hofmann F, Woodgett JR, Nakamura K, Chung UI, Kawaguchi H (2008) Phosphorylation of GSK-3beta by cGMP-dependent protein kinase II promotes hypertrophic differentiation of murine chondrocytes. J Clin Invest 118(7):2506-2515
288. Yaroslavskiy BB, Zhang Y, Kalla SE, Garcia Palacios V, Sharrow AC, Li Y, Zaidi M, Wu C, Blair HC (2005) NO-dependent osteoclast motility: Reliance on cGMP-dependent protein kinase I and VASP. J Cell Sci 118(Pt 23):5479-5487
289. Yaroslavskiy BB, Turkova I, Wang Y, Robinson LJ, Blair HC (2010) Functional osteoclast attachment requires inositol-1,4,5-trisphosphate receptor-associated cGMP-dependent kinase substrate. Lab Invest 90(10): 1533-1542
290. Lenz A, Bennett M, Skelton WP, Vesely DL (2010) Vessel dilator and C-type natriuretic peptide enhance the proliferation of human osteoblasts. Pediatr Res 68(5):405-408
291. Rangaswami H, Schwappacher R, Marathe N, Zhuang S, Casteel DE, Haas B, Chen Y, Pfeifer A, Kato H, Shattil S, Boss GR, Pilz RB (2010) Cyclic GMP and protein kinase G control a Src-containing mechanosome in osteoblasts. Sci Signal 3(153):ra91
292. Marathe N, Rangaswami H, Zhuang S, Boss GR, Pilz RB (2012) Pro-survival effects of 17beta-estradiol on osteocytes are mediated by nitric oxide/cGMP via differential actions of cGMP-dependent protein kinases I and II. J Biol Chem 287(2):978-988
293. Chow JW, Fox SW, Lean JM, Chambers TJ (1998) Role of nitric oxide and prostaglandins in mechanically induced bone formation. J Bone Miner Res 13(6):1039-1044
294. Spinas GA, Laffranchi R, Francoys I, David I, Richter C, Reinecke M (1998) The early phase of glucose-stimulated insulin secretion requires nitric oxide. Diabetologia 41(3): 292-299
295. Panagiotidis G, Alm P, Lundquist I (1992) Inhibition of islet nitric oxide synthase increases arginine-induced insulin release. Eur J Pharmacol 229(2-3):277-278
296. Alm P, Ekstrom P, Henningsson R, Lundquist I (1999) Morphological evidence for the existence of nitric oxide and carbon monoxide pathways in the rat islets of Langerhans: An immunocytochemical and confocal microscopical study. Diabetologia 42(8):978-986
297. Schmidt HH, Warner TD, Ishii K, Sheng H, Murad F (1992) Insulin secretion from pancreatic B cells caused by L-argininederived nitrogen oxides. Science 255(5045): 721-723
298. Salehi A, Carlberg M, Henningson R, Lundquist I (1996) Islet constitutive nitric oxide synthase: Biochemical determination and regulatory function. Am J Physiol 270(6 Pt 1):C1634-C1641
299. Leiss V, Friebe A, Welling A, Hofmann F, Lukowski R (2011) Cyclic GMP kinase I modulates glucagon release from pancreatic alpha-cells. Diabetes 60(1):148-156
300. Lutz SZ, Hennige AM, Feil S, Peter A, Gerling A, Machann J, Krober SM, Rath M, Schurmann A, Weigert C, Haring HU, Feil R (2011) Genetic ablation of cGMP-dependent protein kinase type I causes liver in fl ammation and fasting hyperglycemia. Diabetes 60(5):1566-1576
301. Haas B, Mayer P, Jennissen K, Scholz D, Berriel Diaz M, Bloch W, Herzig S, Fassler R, Pfeifer A (2009) Protein kinase G controls brown fat cell differentiation and mitochondrial biogenesis. Sci Signal 2(99):ra78. doi: 10.1126/scisignal.2000511